69 related articles for article (PubMed ID: 26121332)
21. Artificial Cell-Penetrating Peptide Containing Periodic α-Aminoisobutyric Acid with Long-Term Internalization Efficiency in Human and Plant Cells.
Terada K; Gimenez-Dejoz J; Miyagi Y; Oikawa K; Tsuchiya K; Numata K
ACS Biomater Sci Eng; 2020 Jun; 6(6):3287-3298. PubMed ID: 33463179
[TBL] [Abstract][Full Text] [Related]
22. Biophysical analysis of the MHR motif in folding and domain swapping of the HIV capsid protein C-terminal domain.
Bocanegra R; Fuertes MÁ; Rodríguez-Huete A; Neira JL; Mateu MG
Biophys J; 2015 Jan; 108(2):338-49. PubMed ID: 25606682
[TBL] [Abstract][Full Text] [Related]
23. Rational design of a series of novel amphipathic cell-penetrating peptides.
Regberg J; Srimanee A; Erlandsson M; Sillard R; Dobchev DA; Karelson M; Langel U
Int J Pharm; 2014 Apr; 464(1-2):111-6. PubMed ID: 24463071
[TBL] [Abstract][Full Text] [Related]
24. Medicinal chemistry strategies of targeting HIV-1 capsid protein for antiviral treatment.
Xu S; Sun L; Huang B; Liu X; Zhan P
Future Med Chem; 2020 Jul; 12(14):1281-1284. PubMed ID: 32483985
[No Abstract] [Full Text] [Related]
25. Nucleic acid delivery by cell penetrating peptides derived from dengue virus capsid protein: design and mechanism of action.
Freire JM; Veiga AS; Rego de Figueiredo I; de la Torre BG; Santos NC; Andreu D; Da Poian AT; Castanho MA
FEBS J; 2014 Jan; 281(1):191-215. PubMed ID: 24286593
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of mutual azo prodrugs of anti-inflammatory agents and peptides facilitated by α-aminoisobutyric acid.
Kennedy DA; Vembu N; Fronczek FR; Devocelle M
J Org Chem; 2011 Dec; 76(23):9641-7. PubMed ID: 22026631
[TBL] [Abstract][Full Text] [Related]
27. The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor.
Ternois F; Sticht J; Duquerroy S; Kräusslich HG; Rey FA
Nat Struct Mol Biol; 2005 Aug; 12(8):678-82. PubMed ID: 16041386
[TBL] [Abstract][Full Text] [Related]
28. α-Aminoisobutyric Acid-Containing Amphipathic Helical Peptide-Cyclic RGD Conjugation as a Potential Drug Delivery System for MicroRNA Replacement Therapy in Vitro.
Taniguchi K; Wada SI; Ito Y; Hayashi J; Inomata Y; Lee SW; Tanaka T; Komura K; Akao Y; Urata H; Uchiyama K
Mol Pharm; 2019 Nov; 16(11):4542-4550. PubMed ID: 31596588
[TBL] [Abstract][Full Text] [Related]
29. Structure-based design of a constrained peptide mimic of the HIV-1 V3 loop neutralization site.
Ghiara JB; Ferguson DC; Satterthwait AC; Dyson HJ; Wilson IA
J Mol Biol; 1997 Feb; 266(1):31-9. PubMed ID: 9054968
[TBL] [Abstract][Full Text] [Related]
30. Optimization of a 1,5-dihydrobenzo[b][1,4]diazepine-2,4-dione series of HIV capsid assembly inhibitors 1: addressing configurational instability through scaffold modification.
Fader LD; Landry S; Morin S; Kawai SH; Bousquet Y; Hucke O; Goudreau N; Lemke CT; Bonneau P; Titolo S; Mason S; Simoneau B
Bioorg Med Chem Lett; 2013 Jun; 23(11):3396-400. PubMed ID: 23583513
[TBL] [Abstract][Full Text] [Related]
31. Cell-penetrating, dimeric α-helical peptides: nanomolar inhibitors of HIV-1 transcription.
Jang S; Hyun S; Kim S; Lee S; Lee IS; Baba M; Lee Y; Yu J
Angew Chem Int Ed Engl; 2014 Sep; 53(38):10086-9. PubMed ID: 25056130
[TBL] [Abstract][Full Text] [Related]
32. Novel cell-penetrating peptides based on α-aminoxy acids.
Ma Y; Yang D; Ma Y; Zhang YH
Chembiochem; 2012 Jan; 13(1):73-9. PubMed ID: 22162305
[TBL] [Abstract][Full Text] [Related]
33. Conjugation of cell-penetrating peptides to parathyroid hormone affects its structure, potency, and transepithelial permeation.
Kristensen M; de Groot AM; Berthelsen J; Franzyk H; Sijts A; Nielsen HM
Bioconjug Chem; 2015 Mar; 26(3):477-88. PubMed ID: 25611217
[TBL] [Abstract][Full Text] [Related]
34. Covalent stabilization of coiled coils of the HIV gp41 N region yields extremely potent and broad inhibitors of viral infection.
Bianchi E; Finotto M; Ingallinella P; Hrin R; Carella AV; Hou XS; Schleif WA; Miller MD; Geleziunas R; Pessi A
Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12903-8. PubMed ID: 16129831
[TBL] [Abstract][Full Text] [Related]
35. Noncationic Rigid and Anisotropic Coiled-Coil Proteins Exhibit Cell-Penetration Activity.
Nakayama N; Hagiwara K; Ito Y; Ijiro K; Osada Y; Sano K
Langmuir; 2015 Aug; 31(30):8218-23. PubMed ID: 26196057
[TBL] [Abstract][Full Text] [Related]
36. Dendrimers as potential inhibitors of the dimerization of the capsid protein of HIV-1.
Doménech R; Abian O; Bocanegra R; Correa J; Sousa-Herves A; Riguera R; Mateu MG; Fernandez-Megia E; Velázquez-Campoy A; Neira JL
Biomacromolecules; 2010 Aug; 11(8):2069-78. PubMed ID: 20690715
[TBL] [Abstract][Full Text] [Related]
37. Site-specific PEGylation of HR2 peptides: effects of PEG conjugation position and chain length on HIV-1 membrane fusion inhibition and proteolytic degradation.
Danial M; van Dulmen TH; Aleksandrowicz J; Pötgens AJ; Klok HA
Bioconjug Chem; 2012 Aug; 23(8):1648-60. PubMed ID: 22770564
[TBL] [Abstract][Full Text] [Related]
38. Protein promiscuity: drug resistance and native functions--HIV-1 case.
Fernández A; Tawfik DS; Berkhout B; Sanders R; Kloczkowski A; Sen T; Jernigan B
J Biomol Struct Dyn; 2005 Jun; 22(6):615-24. PubMed ID: 15842167
[TBL] [Abstract][Full Text] [Related]
39. The N-Terminal T-T Motif of a Third-Generation HIV-1 Fusion Inhibitor Is Not Required for Binding Affinity and Antiviral Activity.
Chong H; Qiu Z; Su Y; He Y
J Med Chem; 2015 Aug; 58(16):6378-88. PubMed ID: 26256053
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and antiviral evaluation of new N-acylhydrazones containing glycine residue.
Tian B; He M; Tan Z; Tang S; Hewlett I; Chen S; Jin Y; Yang M
Chem Biol Drug Des; 2011 Mar; 77(3):189-98. PubMed ID: 21306567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
